Skip to main content
. 2018 Sep 5;23(2):489–498. doi: 10.1007/s10461-018-2239-6

Fig. 2.

Fig. 2

Mean number of moderate, severe or very severe side effects reported at 6 months by patients endorsing each of the BMQ ART-Concerns items at baseline